Open AccessThe Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy
Author(s) -
Zhanwang Xiang,
Zhihui Zhong,
Luwen Mu,
Guohong Li,
Churen Zhou,
Haofan Wang,
Mingsheng Huang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s313438
Subject(s) - medicine , brachytherapy , lung cancer , chemotherapy , tumor progression , radiology , radiation therapy , oncology , progression free survival , cancer , nuclear medicine
To further evaluate the efficacy and safety of computed tomography (CT)-guided iodine 125 ( 125 I) brachytherapy to treat locally advanced non-small cell lung cancer (NSCLC) after progression of concurrent radiochemotherapy (CCRT).